A r t i c l e s Interleukin 17 (IL-17)-producing helper T cells (T H 17 cells) were classified as an additional effector CD4 + T cell subset on the basis of their independence of the transcription factors GATA-3 and T-bet that, together with the marker cytokines interferon γ (IFN-γ) and IL-4, define T helper type 1 (T H 1) and T H 2 cells, respectively 1, 2 . The identification of IL-6 and transforming growth factor-β (TGF-β) as differentiation factors 3 , as well as RORγt and RORα as lineagedefining transcription factors 4, 5 , finalized the acceptance of T H 17 as a separate subset. Nevertheless, it was soon clear that T H 17 cells have considerable plasticity and readily acquire the ability to produce IFN-γ in addition to IL-17 production or completely shut off IL-17 production in vitro [6] [7] [8] [9] [10] , which explains the initial erroneous assumption that these cells may have diverged from a common T H 1 precursor 11 . Although extensive plasticity has been attributed to T H 17 cells generated in vitro, it has been suggested that T H 17 cells that develop in vivo retain their phenotype 12 . Because many additional stimuli influence T H 17 differentiation, including cytokines, as well as environmental factors acting through the aryl hydrocarbon receptor (AhR) 13 , it is conceivable that the requirements for full effector differentiation of T H 17 cells are not met in vitro. Thus, it would be advantageous to analyze more closely T H 17 cells that have developed in vivo to determine whether plasticity is also detectable under these conditions. We therefore decided to generate a T H 17 reporter system that would allow not only the identification but also fate mapping of these cells in vivo. To noninvasively trace cells expressing IL-17, we inserted sequence encoding Cre recombinase into the Il17a locus (called 'Il17a Cre ' here). To visualize Cre activity, we crossed Il17a Cre mice with reporter mice expressing enhanced yellow fluorescence protein (eYFP) from the Rosa26 promoter (called 'Rosa26 eYFP ' here). In this mouse strain, the fluorescent reporter permanently labels Il17a Cre cells, which allows the identification of cells that have switched on the IL-17 program as well as alternative effector programs that might have been activated.
Here we show that eYFP expression was induced exclusively under T H 17 conditions and gradually increased during effector differentiation in vivo and that terminally differentiated effector cells all coexpressed IL-17 and eYFP. However, T H 17 cells rapidly lost IL-17A expression in the course of inflammatory immune responses in vivo. Fate determination of cells that had produced IL-17 before their conversion by IL-23 (called 'ex-T H 17 cells' here) under different inflammatory conditions showed they had distinct capacities for alternative fates depending on whether the inflammatory conditions were chronic or acute and rapidly resolved. For example, in the course of the induction of experimental autoimmune encephalomyelitis (EAE), eYFP + cells resident in the inflamed spinal cord did not express IL-17A protein anymore, and a considerable proportion produced IFN-γ instead. In contrast, in acute cutaneous infection with Candida albicans, IL-17A production also was shut down but there was no deviation of eYFP + cells to IFN-γ production. In this model, eYFP + IL-17 − cells seemed quiescent in terms of cytokine production and rapidly decayed.
Those results suggested that the fate of T H 17 cells is shaped by different inflammatory conditions in vivo, which allows distinct patterns of plasticity. Whereas pathogenicity in chronic inflammatory conditions is linked to the expression of additional proinflammatory cytokines, clearance of an infection that results in resolution creates an anti-inflammatory environment that precludes T H 17 cell plasticity and the adoption of the production of alternative cytokines.
A r t i c l e s RESULTS Generation of IL-17A fate-reporter mouse To obtain an IL-17A-specific reporter that would allow us to trace Il17a-expressing cells, we generated a knock-in mouse strain bearing a gene encoding Cre recombinase in the Il17a locus (Il17a Cre ; Supplementary Fig. 1 ). We monitored Cre activity by breeding those mice with reporter mice expressing eYFP from the Rosa26 promoter, generating IL-17A reporter mice (Il17a Cre R26R eYFP ), which allowed us to visualize cells that had activated the IL-17 program regardless of their present production of this cytokine. Analysis of tissues from nonimmune reporter mice demonstrated eYFP + cells in hematopoietic cells of spleen and small intestine lamina propria, in line with a published description of the distribution of IL-17A-producing T cells of both the CD4 + and γδ T cell lineages 4 . A CD4 − CD8 − T cell antigen receptor-positive (TCR + ) natural killer T cell population in the spleen was marked by eYFP, but we detected no reporter expression in NKp46 + cells (Supplementary Fig. 2a ). A CD45 + population of lineage-negative cells that included lymphoid tissue-inducer-like cells 14 , some of which expressed CD4 + , was also marked by eYFP ( Supplementary Fig. 2b ). In the skin, a sizeable fraction of γδ T cells, but very few CD4 + T cells, were eYFP + (Supplementary Fig. 2c) .
In vitro stimulation of flow cytometry-purified naive CD4 + T cells under T H 17 conditions generated a population of T H 17 cells that were detectable by intracellular staining for IL-17A as well as eYFP expression. There was no induction of eYFP under conditions that led to polarization to the T H 1, T H 2, T H 9 or inducible regulatory T cell subset ( Fig. 1a) . Intracellular IL-17A expression without eYFP expression was exaggerated after restimulation with phorbol-12-13-dibutyrate (PdBU) and ionomycin, which may induce early commitment to IL-17 production before full effector status is achieved. In contrast, stimulation with antibody to CD3 (anti-CD3) resulted in higher concordance between IL-17A expression and eYFP expression ( Supplementary Fig. 3 ).
To investigate whether the discrepancy noted above was caused by aberrant expression of eYFP from the recombined Rosa26 eYFP locus, we did PCR amplification of genomic DNA isolated from purified eYFP − IL-17A + CD4 + T cells ( Fig. 1b, gate 1 ) and eYFP − IL-17A − CD4 + T cells ( Fig. 1b, gate2 ), as well as eYFP + CD4 + T cells ( Fig. 1b, gate 3 ). Analysis of the Rosa26 eYFP locus showed that eYFP − IL-17A + cells had not undergone Cre-mediated recombination (gate 1), similar to cells that had not switched on IL-17A production at all (gate 2) and in contrast to eYFP + cells in gate 3. As T H 17 cells that failed to express eYFP had less intracellular IL-17A protein, this suggested that Il17a transcription and therefore protein concentrations of Cre recombinase were below a threshold critical for the induction of recombination ( Fig. 1c) . In line with that assumption, intracellular staining for Cre protein was much lower in eYFP − IL-17A-producing cells than in eYFP + IL-17 + cells ( Fig. 1c ). About 50% of T H 17 cells isolated from naive mice and stimulated with PdBU and ionomycin coexpressed eYFP and IL-17A ex vivo, whereas more than 70% of γδ T cells showed coexpression of eYFP and IL-17A. Neither CD4 + nor γδ eYFP + cells isolated from naive mice expressed IFN-γ ( Fig. 1d,e ). Thus, IL-17A was faithfully marked by eYFP once T H 17 cells had acquired full effector function.
In vivo kinetics of the expression of eYFP and IL-17
To evaluate the kinetics of eYFP reporter expression and the stability of IL-17 cytokine expression in vivo, we immunized mice with myelin oligodendrocyte glycoprotein peptide in complete Freund's adjuvant (MOG-CFA) to induce EAE, a T H 17-dependent chronic autoimmune disease. We assessed the expression of IL-17A protein and eYFP in CD4 + T cells and γδ T cells isolated from draining lymph nodes of mice immunized with MOG-CFA ( Fig. 2a and Supplementary  Fig. 4a) . In both T cell subsets, the percentage of cells expressing both IL-17A and eYFP increased over time, with coexpression more pronounced and complete in γδ T cells than in T H 17 cells. The absolute number of eYFP + CD4 + T H 17 cells increased over time, whereas eYFP + γδ T cells, although they became the dominant population in the total γδ T cell pool, did not increase in absolute number (Fig. 2b) . In the spinal cords of mice that succumbed to disease, most IL-17Aexpressing T cells also expressed eYFP ( Fig. 2c,d and Supplementary  Fig. 4b ), but γδ T cells represented only a minority of infiltrating T cells. Staining for Ki67, a cellular marker of proliferation, showed that eYFP + T H 17 cells from the draining lymph nodes had a higher proliferation rate than that of eYFP − cells at day 12 ( Fig. 2e) . In contrast, basal proliferation in nonimmune mice (day 0) and proliferation in the spinal cord were similar for eYFP − and eYFP + cells. Many eYFP + T H 17 cells in the draining lymph nodes were already negative for IL-17A early after immunization, whereas most γδ T cells remained doubly positive for both eYFP and IL-17A ( Fig. 2a) . Similarly, in the spinal cords of mice with disease (around day 15), only a fraction of the eYFP + CD4 + cells still expressed IL-17A protein, whereas most γδ T cells remained IL-17A + (Fig. 2c) .
IFN-g expression by eYFP + ex-T H 17 cells during EAE
Published reports have demonstrated the presence of cells producing both IL-17A and IFN-γ in inflamed tissues 4, 15 , but the developmental origin of such cells has remained unclear. We therefore determined the source of IFN-γ-producing cells in lymph nodes and spinal cords of mice immunized with MOG-CFA. At day 3, CD4 + T cells in the draining lymph nodes expressed little IFN-γ and originated exclusively from eYFP − T H 1 cells. A greater proportion of γδ T cells expressed IFN-γ, again mostly from the eYFP − fraction ( Fig. 3a) . IFN-γ expression increased over time mainly in eYFP + CD4 + T cells, whereas IFN-γ expression decreased in γδ T cells ( Fig. 3a and Supplementary Fig. 4a ). We compared the effect of restimulation with PdBU and ionomycin, antigen-specific restimulation with MOG peptide or restimulation with anti-CD3 and observed that A r t i c l e s antigen-specific restimulation of cells from draining lymph nodes resulted in much higher concordance between IL-17A expression and eYFP expression ( Fig. 3b and Supplementary  Fig. 5a ). In the spinal cord, half the eYFP + CD4 + T cells switched off IL-17A expression, and almost all of the IFN-γ in CD4 + T cells was derived from eYFP + ex-T H 17 cells. In contrast, eYFP + γδ T cells remained IL-17A + and did not switch to IFN-γ expression ( and Supplementary Fig. 5b) . Comparison of the effect of restimulation with MOG peptide or with PdBU and ionomycin ( Fig. 3d ) confirmed that MOG-specific IFN-γ was derived mostly from ex-T H 17 cells, with only a small fraction of eYFP − T H 1 cells contributing to the expression of this cytokine. There was no switch of eYFP + cells to expression of the transcription factor Foxp3 ( Supplementary  Fig. 5c ), which showed that eYFP + cells that cease production of IL-17A do not deviate toward a regulatory phenotype. Thus, our data show that under chronic inflammatory conditions during EAE, T H 17 cells rapidly switch to the production of IFN-γ and represent the main source of this cytokine.
Cytokine production by CD4 + T cells during EAE
We next analyzed both eYFP + and eYFP − CD4 + T cells isolated from lymph nodes or from spinal cord at 6 d or 15 d after immunization with MOG-CFA, respectively, to evaluate the expression of additional cytokines ( Fig. 4 and Supplementary Fig. 6 ). Most eYFP + cells from the lymph nodes of nonimmunized mice expressed IL-17A without any IFN-γ and also showed some coexpression of granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor (TNF), IL-2 and IL-17F but very little IL-22 expression ( Fig. 4a) . A proportion of eYFP + cells acquired IFN-γ expression at day 6 after immunization. These cells mostly coexpressed IL-17A and had much higher expression of GM-CSF, IL-2 and IL-22. All IL-17A + cells coexpressed TNF at that stage, whereas expression of IL-17F remained at baseline (Fig. 4a) . The spinal cord had lower IL-17A expression, and although coexpression of IL-17A with IFN-γ, GM-CSF and TNF was still evident, a sizeable proportion of cells produced IFN-γ, GM-CSF and TNF in the absence of IL-17A expression. Notably, in the spinal cord population, there was no IL-17F expression and a much smaller proportion of IL-22-producing cells (Fig. 4a) . With the exception of TNF and IL-2, the eYFP − fraction had low expression of all cytokines (Fig. 4b) .
Measurement of cytokine protein concentrations from sorted, restimulated eYFP + and eYFP − cells confirmed the predominant cytokine secretion from the eYFP + population. IL-17A, IFN-γ, GM-CSF and TNF were about tenfold higher in the spinal cord than in draining lymph nodes despite the lower expression profiles found by intracellular staining (Fig. 4c) . The progressive development of eYFP + cells from being predominantly IFN-γ − IL-17A-secreting cells to being IFN-γ + IL-17A + cells and finally to expressing IFN-γ alone suggests that alternative cell fates are adopted during the development of effector cells. Thus, proinflammatory cytokines produced by effector cells in the spinal cord were derived almost exclusively from ex-T H 17 cells with no apparent contribution from T H 1 cells. those populations and to unequivocally prove that the source of IFN-γ was a cell with characteristics of a T H 17 program rather than a T H 1 program, we used an adoptive-transfer model. Because loss of IL-17A protein expression is accompanied by loss of expression of the chemokine receptor CCR6, we immunized mice with MOG-CFA and 4 d later purified CCR6 + eYFP + CD4 + cells from draining lymph nodes by flow cytometry. To optimize cell yield and adoptive transfer, we used reporter mice with transgenic expression of the 2D2 TCR specific for MOG 16 . We then transferred 1 × 10 4 CCR6 + eYFP + CD4 + T cells into mice deficient in the recombinase component RAG-1, which we immunized with MOG-CFA to mimic the chronic inflammation of EAE. At the same time we did single-cell PCR analysis of the starting inoculum of CCR6 + eYFP + CD4 + T cells to assess ongoing transcription of Il17a and Ifng (Supplementary Table 1) . About 30% of the adoptively transferred eYFP + T H 17 cells produced IFN-γ in the lymph nodes, compared with 60% of such cells in the spinal cord ( Fig. 5a) .
Transcriptional changes in ex-T H 17 cells
Single-cell RT-PCR confirmed that most cells expressed Il17a and little Ifng at the time of transfer ( Supplementary Table 1 ).
Next we induced EAE in the Il17a Cre R26R eYFP reporter mice and isolated CCR6 + eYFP + and CCR6 − eYFP + CD4 + cells from the spinal cord to analyze their transcriptional profiles. As shown by flow cytometry of the sorted populations (Fig. 5b) , the CCR6 + eYFP + population contained the most cells producing only IL-17A, with few cells producing both IFN-γ and IL-17A. In contrast, the CCR6 − eYFP + fraction contained most of the cells producing both IFN-γ and IL-17A, as well as cells producing only IFN-γ, but few cells producing only IL-17A. CCR6 − eYFP + cells downregulated Il17a mRNA and upregulated Ifng mRNA, consistent with the protein expression data. CCR6 + eYFP + and CCR6 − eYFP + cells had equal expression of the gene encoding the IL-12Rβ2 receptor subunit shared by IL-12 and IL-23, whereas only the CCR6 − cells upregulated expression of the genes encoding IL-12Rβ2 and T-bet, whereas they downregulated expression of the genes encoding RORγt and the IL-23 receptor. Similar transcriptional changes have been reported in T H 17 cells generated in vitro, with the exception of IL-12Rβ2, which is not switched off in vitro 7 but was absent on IL-17Aexpressing cells developing in vivo (Fig. 5b) . Notably, we were able to distinguish IFN-γ-producing ex-T H 
cells from T H 1 producers of IFN-γ by expression of the gene encoding AhR, which remained high in CCR6 − eYFP + cells, and by IL-1R1 expression. The latter was absent from T H 1 cells in lymphoid tissue and had low expression on T H 1 cells from the spinal cord. In contrast, eYFP + cells expressing IL-17A
as well as IFN-γ had high expression of IL-1R1 (Fig. 5c) . To test the functional importance of IL-1R1 expression, we purified eYFP + and eYFP − CD4 + CD44 hi T cells from the draining lymph nodes and spinal cords of MOG-CFA-immunized mice by flow cytometry and stimulated the cells in the presence of IL-1β. This resulted in considerable enhancement of the production of IL-17A as well as IFN-γ exclusively from the eYFP + fraction, in agreement with the expression pattern of A r t i c l e s IL-1R1 (Fig. 5d) . Thus, IL-1R1 expression could potentially be used as a marker for IFN-γ-producing cells not derived from T H 1 cells.
T H 1-like effector profile in ex-T H 17 cells depends on IL-23
The importance of IL-23 signaling in the differentiation of T H 17 effector cells is well established 17 . Furthermore, on the basis of in vitro studies, IL-23 is thought to contribute to the functional deviation of T H 17 cells 8 .
To determine the role of IL-23 signaling in our fate reporter model, we crossed IL-23p19-deficient mice with the Il17a Cre R26R eYFP reporter mice and immunized the progeny with MOG-CFA. Although the IL-23p19-deficient reporter mice developed a much smaller proportion of eYFP + CD4 + T cells than wild-type reporter mice did, the proportion of cells producing only IL-17A after stimulation with PdBU and ionomycin was similar in wild-type and IL-23p19-deficient reporter mice (Fig. 6a) . However, the eYFP + cells from these IL-23p19-deficient reporter mice lacked IL-17A + IFN-γ + cells as well as solely IFN-γ + cells, in contrast to cells from the wild-type mice. This phenotype was more pronounced after restimulation with MOG peptide, after which the proportion of cells producing both IL-17A and IFN-γ among eYFP + cells was much lower than after stimulation with PdBU and ionomycin, even in wild-type mice, and was completely absent from the IL-23p19-deficient reporter mice (Fig. 6b) . To pinpoint the mechanistic link between IL-23 and the deviation toward a T H 1-like profile, we assessed T-bet expression in eYFP + and eYFP − CD4 + T cells from wild-type and IL-23p19-deficient reporter mice. The absence of IL-23 signaling in T H 17 cells prevented T-bet upregulation (Fig. 7) , which suggests that this transcription factor is controlled by IL-23. Together these data support our initial assumption that developmental progression of effector cell differentiation proceeds via an eYFP + stage before IL-17A is switched off and alternative fates are adopted. Furthermore, they suggest that IL-23 stimulation is not only crucial for attaining full effector function, as shown before, but also necessary for double expression of IL-17A and IFN-γ, induction of T-bet and subsequent deviation toward IFN-γ production.
T H 17 cell plasticity in inflammatory conditions
The developmental plasticity of T H 17 cells toward a T H 1-like phenotype has been well documented in models of autoimmune diseases 18 , but it is unclear whether these cells can adopt other effector fates under inflammatory conditions that do not result in autoimmunity.
To explore this issue, we cutaneously infected the Il17a Cre R26R eYFP reporter mice with Candida albicans hyphae. IL-17-producing γδ T cells and T H 17 cells are important for the defense against this fungal infection, as showed by the severe mucocutaneous infections with candida that develop in patients with defective IL-17 responses [19] [20] [21] .
In contrast to the chronic inflammation of EAE, infection with C. albicans leads to an acute infection that is rapidly cleared. Here we found that infection was accompanied by infiltration of neutrophils (Supplementary Fig. 7) and an early innate IL-17A response mediated by γδ T cells, as well as progressive involvement of T H 17 cells (Fig. 8a) . By day 3 after infection, the majority of both γδ T cells and A r t i c l e s CD4 + T cells expressing IL-17A also expressed eYFP. However, by day 5, when C. albicans was cleared (data not shown), a large fraction of eYFP + cells had switched off IL-17A expression, and by day 8, the absolute number of infiltrating CD4 + T cells (both eYFP + and eYFP − ) and γδ T cells was much lower (Fig. 8b) . Infection with C. albicans also elicited a substantial IFN-γ response by CD4 + T cells, but in contrast to the results we obtained with inflamed spinal cords during EAE, almost none of these were eYFP + , indicative of their T H 1 origin (Fig. 8c) . The eYFP + population that had switched off IL-17A seemed quiescent in terms of cytokine expression, as they did not express IL-22, GM-CSF or IL-17F once IL-17A expression was extinguished ( Fig. 8d) . Quantitative PCR analysis of CD11b + and CD11c + cells isolated from infected skin showed high Il10 expression and relatively low Il23a expression ( Fig. 8e) , which suggests that the milieu in the surrounding skin tissue is biased toward an anti-inflammatory profile that may curtail the deviation of T H 17 cells toward alternative fates. The data reported above suggest that in contrast to chronic inflammation, acute inflammation promotes an anti-inflammatory environment in which T H 17 cells downregulate Il17a transcriptional activity without activating loci encoding alternative cytokines. Thus, resolution of acute inflammation goes hand in hand with the disappearance of T H 17 and γδ T cells rather than a switch to the alternative effector fates that we characterized during chronic inflammation.
DISCUSSION
Lineage commitment and fate determination are fundamental biological processes that have been studied extensively in a variety of biological systems. In T cell biology, these issues, combined with the question of terminal differentiation, stability or plasticity, have been discussed and investigated intensively. To some extent the unusual biology of the T H 17 subset has triggered these questions, although they are by no means restricted to T H 17 cell biology and indeed are now being explored in other effector T cell subsets as well 22, 23 .
Given the documented rapid fate changes of cultured T H 17 cells in vitro and after adoptive transfer, driven by epigenetic instability at loci encoding transcription factors as well as cytokines 24, 25 , the logical choice was to generate a reporter mouse that would allow permanent tracing of cells with activation of the locus encoding the signature cytokine IL-17A. The reporter mouse we generated is to our knowledge the first fate-reporter mouse for IL-17A, as existing mice generated so far by transgenesis of a bacterial artificial chromosome allow only monitoring of transcriptional activity at the closely linked Il17f locus 26 . IL-17F is largely coexpressed with IL-17A in lymphoid organs and may have an important role in lung inflammation, but we found little IL-17F expression during neuronal inflammation, in agreement with the fact that IL-17F deficiency does not protect from EAE 27 . We have provided experimental evidence showing that induction of the eYFP reporter correlated well with effector function. Our data also indicated that T H 17 cells generated in vitro did not attain the same degree of effector differentiation noted in vivo during the course of inflammatory immune responses that lead to IL-17A induction. Even the few IL-17A-expressing CD4 + and γδ T cells found in lymphoid organs of mice without deliberate immunization included a greater proportion of eYFP + cells than were detected during the in vitro differentiation of T H 17 cells. It is likely that many factors that shape T H 17 differentiation in vivo are not adequately mimicked by in vitro conditions.
A published study has suggested that in contrast to T H 17 cells differentiated in vitro, T H 17 cells generated in vivo seem developmentally stable 12 . From our study it was evident that T H 17 cells activated in vivo also rapidly shut off IL-17A production. This process closely followed the acquisition of eYFP in reporter mice expressing Cre from the Il17a locus, as there was almost no evidence for direct progression of cells producing IL-17A to those producing IFN-γ, bypassing the eYFP + effector stage. Notably, analysis of T H 17 development in IL-23p19-deficient reporter mice showed not only less acquisition of A r t i c l e s eYFP but also lack of the double-positive IL-17 + IFN-γ + population that usually develops after immunization in vivo. This suggests that T H 17 cells require prior effector cell differentiation to produce IFN-γ. Similar observations have been made in the investigation of intestinal T H 17 cell responses in mice deficient in the IL-23 receptor 28 .
As T-bet expression was considerably curtailed in T H 17 cells from reporter mice deficient in IL-23p19, it is likely that IL-23 is upstream of T-bet and is required for its expression. IL-23 is abundant during chronic inflammation 29 but is downregulated during resolution of the inflammatory response, which makes IL-23 perhaps the main 'decision point' for T H 17 cell plasticity. Furthermore, it was evident that the eYFP + population constituted the main source of other cytokines. Notably, GM-CSF, which is linked to EAE 30, 31 , was produced exclusively by eYFP + T H 17 and ex-T H 17 cells. The propensity for a switch to IFN-γ production was pronounced in the setting of EAE and was accompanied by upregulation of IL-12Rβ2 and T-bet and downregulation of RORγt, the IL-23 receptor and CCR6. Notably, AhR expression was retained, thus making IFNγ-producing ex-T H 17 cells susceptible to environmental stimuli. In contrast to in vitro-generated T H 17 cells from mice or humans, which retain expression of both IL-12R chains 7, 32 , T H 17 cells developing in vivo did not express the IL-12Rβ2 chain, which made such cells refractory to the action of IL-12. Furthermore, stimulation of AhR, which has high expression on T H 17 cells, leads to upregulation of both IL-12Rβ1 and IL-12Rβ2 (ref. 33) . Published data have shown that T H 2 cells, which switch off IL-12Rβ2 during differentiation in vitro 34 , reexpress the receptor when exposed to type I interferon or IFN-γ 35 . Similar mechanisms may contribute to the reinduction of IL-12Rβ2 in T H 17 cells during EAE, with potential involvement of plasmacytoid dendritic cells as source of type I interferon 36, 37 . In this context, it is also worth noting that inhibition of intracellular osteopontin dependent on the IFN-α receptor may regulate IL-27 expression and subsequent inhibition of IL-17 (ref. 38) . The relative roles of IL-17A and IFN-γ in the pathology of EAE, as well as in multiple sclerosis in humans, remain controversial, with evidence supporting the proposal of both protective as well as pathogenic involvement of IFN-γ in central nervous system inflammation [39] [40] [41] [42] . Effector cytokines produced by ex-T H 17 cells during the chronic stage may thus have different roles in the pathogenesis of autoimmune diseases.
Our data reconcile seemingly conflicting results obtained by the adoptive transfer of T H 17 or T H 1 cells generated in vitro [42] [43] [44] [45] that seemed to refute the idea of an important role for T H 17 cells in various autoimmune models, in contrast to earlier data highlighting their crucial importance in these models 46 . Our data also explain how T-bet-deficient mice are protected from EAE, which seemed at odds with the proposal of an important role for T H 17 cells in pathology of the central nerous system. It seems that IL-23-mediated induction of T-bet that results in IFN-γ expression by ex-T H 17 cells is an important step in the pathophysiology of EAE, as IFN-γ represents the most abundant cytokine by far in the spinal cords of mice with EAE. Those data also explain published findings that mice with transgenic expression of a dominant negative TGF-β receptor (TGF-βRII) are protected from EAE and contain very few T H 1 cells in the spinal cord despite an overabundance of T H 1 cells throughout the lymphoid organs 29 . Thus, IL-17-producing cells, including innate γδ T cells and natural killer T cells 47 , might have an early role in the recruitment of cells involved in setting up inflammatory responses, whereas the conversion to a T H 1-like cytokine profile may be the main pathological driver. Notably, pathogenic effector T H 17 cells must lose responsiveness to TGF-β to allow effective T-bet expression. It is possible that this could explain the report of pathogenic T H 17 cells that arise in the apparent absence of TGF-β signaling 48 .
In contrast to the results obtained during EAE, a switch from IL-17A production to IFN-γ production was not evident after infection of the skin with C. albicans, which suggests that T H 17 cell plasticity depends on the inflammatory milieu. Whereas immunization with MOG-CFA induces a chronic inflammatory response because of the depot effect of the immunogen emulsion, infection of the skin with C. albicans was rapidly cleared in wild-type mice. The infection caused an early influx of neutrophils sustained by the IL-17A response, which was shut off in parallel with clearance of the neutrophil infiltration. At that stage, the skin milieu was characterized by high expression of IL-10 and relatively modest IL-23 expression, which suggested a balance in favor of an anti-inflammatory microenvironment. The surviving eYFP + but IL-17A − CD4 + population showed minimal detectable cytokine secretion. Such a population of ex-T H 17 cells would be invisible by any other means of detection, as IL-17A secretion was not induced even by stimulation with PdBU and ionomycin. This would explain a published report suggesting that T H 17 cells cannot be detected in the pool of long-lived CD4 + memory T cells 49 . It remains to be determined whether surviving eYFP + cells carry memory of their initial induction and are able to reinitiate a T H 17 program after re-encountering the original pathogen in similar inflammatory settings.
The expression of IL-1R1 on ex-T H 17 cells could be a useful marker for identifying cells that develop through a T H 17 program, as neither T H 1 nor T H 2 cells normally have substantial expression of this receptor, which has been shown to be crucial for the pathogenisis of autoimmune diseases such as EAE 50 . Thus, our data reconcile a host of literature identifying various proinflammatory cytokines, including GM-CSF, IFN-γ and IL-1, in the pathogenisis of autoimmune diseases, as they are all linked to T cells that began their effector stage as T H 17 cells. Together our data suggest that fate of T H 17 cells is shaped by different inflammatory conditions in vivo that allow distinct patterns of plasticity. Thus, IL-17A fate-reporter mice constitute a valuable tool for the delineation of effector cytokine programs that may have originated initially from T H 17 cells and will facilitate mechanistic analysis of the inflammatory drivers that shape acquisition of the functional fate by effector T cells.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
